Executive Committee: Beijing Balance Medical Technology Co.,Ltd.

Manager
Positions heldSince
Lei Jin

Lei Jin

72 year

Chief Executive Officer 2005-07-10
Corporate Secretary 2020-12-10
Jia Wu

Jia Wu

55 year

Chief Tech/Sci/R&D Officer 2010-12-31
Wu Ping Li

Wu Ping Li

48 year

Sales & Marketing 2016-12-31
Li Li Wang

Li Li Wang

45 year

Investor Relations Contact 2017-08-31
Qi Cheng

Qi Cheng

58 year

Director of Finance/CFO 2021-09-13

Composition of the Board of Directors: Beijing Balance Medical Technology Co.,Ltd.

Director
CommitteesSince
Dong Hui Wang

Dong Hui Wang

57 year

Chairman 2011-10-09
Xin Wu

Xin Wu

72 year

Audit Committee 2018-01-31
Compensation Committee Chair 2018-01-31
Nominating Committee Chair 2018-01-31
Lei Jin

Lei Jin

72 year

Audit Committee 2005-07-10
Compensation Committee 2005-07-10
Qiang Liu

Qiang Liu

54 year

Compensation Committee 2018-01-31
Audit Committee Chair 2018-01-31
Yan Fang Li

Yan Fang Li

62 year

Nominating Committee 2018-01-31
Sen Jin

Sen Jin

66 year

Audit Committee
Li Yan Li

Li Yan Li

46 year

Nominating Committee 2005-07-10
Qi Cheng

Qi Cheng

58 year

Director/Board Member 2021-09-13
Wu Ping Li

Wu Ping Li

48 year

Director/Board Member 2021-01-13
Yan Fang Zhang

Yan Fang Zhang

42 year

Director/Board Member 2005-07-10
Hong Mu

Hong Mu

45 year

Director/Board Member 2005-07-10

Former Officers and Directors: Beijing Balance Medical Technology Co.,Ltd.

Insider
Positions held
SinceUntil

Age distribution of managers

Parity Men Women

Male9
Female6

Of which Executive Committee

Male3
Female2

Of which Directors

Male6
Female5
Logo Beijing Balance Medical Technology Co.,Ltd.
Beijing Balance Medical Technology Co Ltd is a China-based company mainly engaged in the research and development (R&D) and production of animal derived interventional medical devices. The Company's products cover three fields: heart valve replacement and repair, implantable interventional therapy for congenital heart disease and surgical soft tissue repair. The heart valve replacement and repair products include artificial biological heart valves and valve forming rings. The implantable interventional therapy products for congenital heart disease include cardiothoracic surgical biological patch, outflow tract single valve patch, atrial defect occlude and others. The surgical soft tissue repair products include neurosurgical biological patch, biological hernia patch and others. The Company operates its businesses mainly in the domestic market.
Employees
611